ValuEngine Downgrades GlaxoSmithKline plc (GSK) to Hold


GSK has been the topic of several other research reports. Zacks Investment Research lowered GlaxoSmithKline plc from a "hold" rating to a "sell" rating in a research report on Monday, April 17th.



from Biotech News